Genetic diversity among multidrug-resistant Mycobacterium tuberculosis strains in Mexico

Infection, Genetics and Evolution

Volumn 14, Issue 1, 2013, Pages 434-443

  Martinez Guarneros, Armando ^a,b   Rastogi, Nalin ^c   Couvin, David ^c   Escobar Gutierrez, Alejandro ^a   Rossi, Livia Maria Gonçalves ^a   Vazquez Chacon, Carlos A ^a   Rivera Gutierrez, Sandra ^b   Lozano, Daniela ^d   Vergara Castañeda, Arely ^e   Gonzalez y Merchand, Jorge A ^b   Vaughan, Gilberto ^a,f  

^a Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c Institut Pasteur de Guadeloupe   (Guadeloupe)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

^e UNIVERSIDAD LA SALLE   (Mexico)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

MDR TB; MIRU VNTR; Mycobacterium tuberculosis; Spoligotyping

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTERSPERSED REPEAT; MALE; MEXICO; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTITUBERCULAR; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DNA, BACTERIAL; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MEXICO; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINISATELLITE REPEATS; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; TOPOGRAPHY, MEDICAL; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84873645095     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.12.024     Document Type: Article

References (29)

1. Banerjee R., Allen J., Westenhouse J., Oh P., Elms W., Desmond E., Nitta A., Royce S., Flood J. Extensively drug-resistant tuberculosis in california, 1993-2006. Clin. Infect. Dis. 2008, 47:450-457.
2. Brudey K., Driscoll J.R., Rigouts L., Prodinger W.M., Gori A., Al-Hajoj S.A., Allix C., Aristimuno L., Arora J., Baumanis V., Binder L., Cafrune P., Cataldi A., Cheong S., Diel R., Ellermeier C., Evans J.T., Fauville-Dufaux M., Ferdinand S., Garcia de Viedma D., Garzelli C., Gazzola L., Gomes H.M., Guttierez M.C., Hawkey P.M., van Helden P.D., Kadival G.V., Kreiswirth B.N., Kremer K., Kubin M., Kulkarni S.P., Liens B., Lillebaek T., Ho M.L., Martin C., Mokrousov I., Narvskaia O., Ngeow Y.F., Naumann L., Niemann S., Parwati I., Rahim Z., Rasolofo-Razanamparany V., Rasolonavalona T., Rossetti M.L., Rusch-Gerdes S., Sajduda A., Samper S., Shemyakin I.G., Singh U.B., Somoskovi A., Skuce R.A., van Soolingen D., Streicher E.M., Suffys P.N., Tortoli E., Tracevska T., Vincent V., Victor T.C., Warren R.M., Yap S.F., Zaman K., Portaels F., Rastogi N., Sola C. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 2006, 6:23.
3. Canetti G., Froman S., Grosset J., Hauduroy P., Langerova M., Mahler H.T., Meissner G., Mitchison D.A., Sula L. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. World Health Organ. 1963, 29:565-578.
4. Chiang C.Y., Lee J.J., Yu M.C., Bai K.J., Lin T.P., Luh K.T. Tuberculosis-related deaths without treatment. Int. J. Tuberc. Lung Dis. 2009, 13:1563-1565.
5. Cox H.S., Sibilia K., Feuerriegel S., Kalon S., Polonsky J., Khamraev A.K., Rusch-Gerdes S., Mills C., Niemann S. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis. N. Engl. J. Med. 2008, 359:2398-2400.
6. Daley C.L. Molecular epidemiology: a tool for understanding control of tuberculosis transmission. Clin. Chest Med. 2005, 26:217-231. vi.
7. David H., Levy-Frebault V., Thorel M.F. Méthodes de laboratoire pour Mycobactériologie clinique 1989, Institut Pasteur, Paris, France.
8. Demay C., Liens B., Burguiere T., Hill V., Couvin D., Millet J., Mokrousov I., Sola C., Zozio T., Rastogi N. SITVITWEB-a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect. Genet. Evol. 2012, 12:755-766.
9. Douglas J.T., Qian L., Montoya J.C., Musser J.M., Van Embden J.D., Van Soolingen D., Kremer K. Characterization of the Manila family of Mycobacterium tuberculosis. J. Clin. Microbiol. 2003, 41:2723-2726.
10. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999, 282:677-686.
11. Garcia-Garcia Mde L., Ponce-De-Leon A., Garcia-Sancho M.C., Ferreyra-Reyes L., Palacios-Martinez M., Fuentes J., Kato-Maeda M., Bobadilla M., Small P., Sifuentes-Osornio J. Tuberculosis-related deaths within a well-functioning DOTS control program. Emerg. Infect. Dis. 2002, 8:1327-1333.
12. Garcia de Viedma D., Bouza E., Rastogi N., Sola C. Analysis of Mycobacterium tuberculosis genotypes in Madrid and identification of two new families specific to Spain-related settings. J. Clin. Microbiol. 2005, 43:1797-1806.
13. Hunter P.R., Gaston M.A. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J. Clin. Microbiol. 1988, 26:2465-2466.
14. Kamerbeek J., Schouls L., Kolk A., van Agterveld M., van Soolingen D., Kuijper S., Bunschoten A., Molhuizen H., Shaw R., Goyal M., van Embden J. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 1997, 35:907-914.
15. Kandula N.R., Dworkin M.S., Carroll M.R., Lauderdale D.S. Tuberculosis prevention in Mexican immigrants: limitations of short-course therapy. Am. J. Prev. Med. 2004, 26:163-166.
16. Kent P.T., Kubica G.P. Public health Mycobacteriology a guide for the level III laboratory 1985, US Department of Health and Human Services Centers for Disease Control, Atlanta, Georgia.
17. Lopez-Alvarez R., Badillo-Lopez C., Cerna-Cortes J.F., Castillo-Ramirez I., Rivera-Gutierrez S., Helguera-Repetto A.C., Aguilar D., Hernandez-Pando R., Samper S., Gonzalez-y-Merchand J.A. First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance. BMC Microbiol. 2010, 10.
18. Martinez-Gamboa A., Ponce-de-Leon A., Galindo-Fraga A., Bobadilla-del-Valle M., Kato-Maeda M., Robertson B.D., Young D.B., Small P.M., Sifuentes-Osornio J. Molecular analysis of Mycobacterium tuberculosis strains with an intact pks15/1 gene in a rural community of Mexico. Arch. Med. Res. 2008, 39:809-814.
19. Martinez-Guarneros A., Vaughan G., Lozano D., Vazquez-Chacon C.A., Bäcker C., Cazares F., Ruiz-Tovar K., Fonseca-Coronado S., Carpio-Pedroza J.C., Vergara-Castañeda A., Escobar-Gutierrez A. Multidrug-resistance (MDR) and extensively drug-resistance (XDR) tuberculosis in Mexico 2012, Scand. J. Infect. Dis., Submitted.
20. Molina-Torres C.A., Moreno-Torres E., Ocampo-Candiani J., Rendon A., Blackwood K., Kremer K., Rastogi N., Welsh O., Vera-Cabrera L. Mycobacterium tuberculosis spoligotypes in Monterrey, Mexico. J. Clin. Microbiol. 2010, 48:448-455.
21. Nava-Aguilera E., Lopez-Vidal Y., Harris E., Morales-Perez A., Mitchell S., Flores-Moreno M., Villegas-Arrizon A., Legorreta-Soberanis J., Ledogar R., Andersson N. Clustering of Mycobacterium tuberculosis cases in acapulco: spoligotyping and risk factors. Clin. Dev. Immunol. 2011, 2011:408375.
22. Quitugua T.N., Seaworth B.J., Weis S.E., Taylor J.P., Gillette J.S., Rosas I.I., Jost K.C., Magee D.M., Cox R.A. Transmission of drug-resistant tuberculosis in Texas and Mexico. J. Clin. Microbiol. 2002, 40:2716-2724.
23. Reed M.B., Pichler V.K., McIntosh F., Mattia A., Fallow A., Masala S., Domenech P., Zwerling A., Thibert L., Menzies D., Schwartzman K., Behr M.A. Major Mycobacterium tuberculosis lineages associate with patient country of origin. J. Clin. Microbiol. 2009, 47:1119-1128.
24. Secretaria de Salud Boletines Epidemiologicos Anuales 2005, Direccion General de Epidemiologia, Mexico City, Mexico.
25. Soini H., Pan X., Amin A., Graviss E.A., Siddiqui A., Musser J.M. Characterization of Mycobacterium tuberculosis isolates from patients in Houston, Texas, by spoligotyping. J. Clin. Microbiol. 2000, 38:669-676.
26. Supply P., Allix C., Lesjean S., Cardoso-Oelemann M., Rusch-Gerdes S., Willery E., Savine E., de Haas P., van Deutekom H., Roring S., Bifani P., Kurepina N., Kreiswirth B., Sola C., Rastogi N., Vatin V., Gutierrez M.C., Fauville M., Niemann S., Skuce R., Kremer K., Locht C., van Soolingen D. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 2006, 44:4498-4510.
27. Supply P., Lesjean S., Savine E., Kremer K., van Soolingen D., Locht C. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J. Clin. Microbiol. 2001, 39:3563-3571.
28. WHO, 2010. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response, in: WHO/HTM/TB/2010.3 (Ed.), World Helath Organization, 2010, Geneva.
29. Zenteno-Cuevas R., Cuevas-Cordoba B., Enciso A., Enciso L., Cuellar A. Assessing the utility of three TaqMan probes for the diagnosis of tuberculosis and resistance to rifampin and isoniazid in Veracruz, Mexico. Can. J. Microbiol. 2012, 58:318-325.